larotrectinib sulfate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
VITRAKVI larotrectinib (as sulfate) 25 mg hard capsule bottle
AUST R: 320237
Active ingredients:
larotrectinib sulfate

Dosage form:
Capsule, hard

Sponsor:
Bayer Australia Ltd

Phone:
1800 008 757

From
21 Jul 2025
to
28 Nov 2025

Shortage status:
Anticipated

Availability:
Available

Reason:
Unexpected increase in consumer demand

Management action:
The sponsor is closely controlling the supply.